RadNet subsidiary DeepHealth plans to share results from a study that explores the identification of incidental lung nodules aided by AI software at the upcoming ECR meeting in Vienna.
The results from the study will be presented during a March 2 session called "Pulmonary Nodules and Lung Cancer Screening" (RPS 2104) by Maurits Engbersen, Clinical Manager, DeepHealth. The research investigated the effect of computer-aided detection on incidental lung nodule management recommendations from a reporting radiologist and an expert peer reviewer, the company said.
The firm also plans to host a panel on February 29 called "Radiologists and AI-powered Health Informatics: Leading the Way in Screening" that will include Marie Pierre Revel, MD, of the University of Paris; Sam Hare, MD, CEO of Heart and Lung Health; and Greg Sorensen, MD, RadNet's CSO and DeepHealth's chief product leader for clinical AI.
